[{"id":"9d3ba8ea-46a0-45f2-ae94-10b7cf3b2f84","acronym":"CAR-T","url":"https://clinicaltrials.gov/study/NCT04723901","created_at":"2021-01-26T15:52:10.678Z","updated_at":"2024-07-02T16:36:35.620Z","phase":"Phase 1/2","brief_title":"Dual Target CAR-T Cells in B-cell Acute Lymphoblastic Leukemia","source_id_and_acronym":"NCT04723901 - CAR-T","lead_sponsor":"Shenzhen University General Hospital","biomarkers":" CD19 • CD22","pipe":" | ","alterations":" CD19 expression • CD22 expression • CD19 underexpression","tags":["CD19 • CD22"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 expression • CD22 expression • CD19 underexpression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19/CD22 dual-target CAR-T"],"overall_status":"Recruiting","enrollment":" Enrollment 20","initiation":"Initiation: 10/20/2020","start_date":" 10/20/2020","primary_txt":" Primary completion: 12/31/2022","primary_completion_date":" 12/31/2022","study_txt":" Completion: 12/31/2022","study_completion_date":" 12/31/2022","last_update_posted":"2021-01-26"}]